Summary by Moomoo AI
Tempus AI, Inc. reported Q2 2024 financial results, with revenue increasing 25% year-over-year to $166.0 million. Data licensing revenue growth accelerated to 40% YoY. The company expanded into the minimal residual disease market and established a joint venture with SoftBank to enter Japan.Tempus raised $410.7 million in gross proceeds from its IPO. Net loss was $552.2 million, largely due to $493.1 million in stock compensation expense related to the IPO. Adjusted EBITDA improved by $12.7 million QoQ to -$31.2 million.For full-year 2024, Tempus expects revenue of ~$700 million, representing ~32% annual growth. The company anticipates adjusted EBITDA of approximately -$105 million, an improvement of ~$50 million over 2023.